WallStreetZenWallStreetZen

NASDAQ: AMLX
Amylyx Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AMLX

Based on 5 analysts offering 12 month price targets for Amylyx Pharmaceuticals Inc.
Min Forecast
$3.00+51.52%
Avg Forecast
$11.00+455.56%
Max Forecast
$32.00+1,516.16%

Should I buy or sell AMLX stock?

Based on 5 analysts offering ratings for Amylyx Pharmaceuticals Inc.
Buy
Strong Buy
2 analysts 40%
Buy
1 analysts 20%
Hold
2 analysts 40%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AMLX stock forecasts and price targets.

AMLX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-03-11Find Out Why
lockedlocked$00.00+00.00%2024-03-11Find Out Why
lockedlocked$00.00+00.00%2024-03-08

1 of 1

Forecast return on equity

Is AMLX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.81%

Forecast return on assets

Is AMLX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

AMLX revenue forecast

What is AMLX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$132.1M-65.31%
Avg 2 year Forecast
$202.7M-46.76%
Avg 3 year Forecast
$650.0k-99.83%
AMLX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AMLX earnings growth forecast

How is AMLX forecast to perform vs Biotechnology companies and vs the US market?
Company
142.34%
Industry
7.3%
Market
21.77%
AMLX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
AMLX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
AMLX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

AMLX revenue growth forecast

How is AMLX forecast to perform vs Biotechnology companies and vs the US market?
Company
-49.09%
Industry
37.64%
Market
10.1%
AMLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AMLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AMLX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AMLX$1.98$11.00+455.56%Buy
VXRT$0.76$2.00+162.47%Strong Buy
LENZ$15.89$31.33+97.19%Strong Buy
SYRS$4.99$14.00+180.56%Strong Buy
OMGA$2.39$10.00+318.41%Strong Buy
View Top Biotech Stocks

Amylyx Pharmaceuticals Stock Forecast FAQ

Is Amylyx Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: AMLX) stock is to Buy AMLX stock.

Out of 5 analysts, 2 (40%) are recommending AMLX as a Strong Buy, 1 (20%) are recommending AMLX as a Buy, 2 (40%) are recommending AMLX as a Hold, 0 (0%) are recommending AMLX as a Sell, and 0 (0%) are recommending AMLX as a Strong Sell.

If you're new to stock investing, here's how to buy Amylyx Pharmaceuticals stock.

What is AMLX's revenue growth forecast for 2024-2026?

(NASDAQ: AMLX) Amylyx Pharmaceuticals's forecast annual revenue growth rate of -49.09% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Amylyx Pharmaceuticals's revenue in 2024 is $380,786,000.On average, 2 Wall Street analysts forecast AMLX's revenue for 2024 to be $8,953,003,830, with the lowest AMLX revenue forecast at $8,918,096,028, and the highest AMLX revenue forecast at $8,987,911,631. On average, 1 Wall Street analysts forecast AMLX's revenue for 2025 to be $13,741,201,911, with the lowest AMLX revenue forecast at $13,741,201,911, and the highest AMLX revenue forecast at $13,741,201,911.

In 2026, AMLX is forecast to generate $44,058,390 in revenue, with the lowest revenue forecast at $44,058,390 and the highest revenue forecast at $44,058,390.

What is AMLX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AMLX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is AMLX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year AMLX price target, the average AMLX price target is $11.00, with the highest AMLX stock price forecast at $32.00 and the lowest AMLX stock price forecast at $3.00.

On average, Wall Street analysts predict that Amylyx Pharmaceuticals's share price could reach $11.00 by Apr 11, 2025. The average Amylyx Pharmaceuticals stock price prediction forecasts a potential upside of 455.56% from the current AMLX share price of $1.98.

What is AMLX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AMLX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.